A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal Cancer

This study has been completed.

Sponsor:

Collaborator:

Immunotope

Information provided by (Responsible Party):

Michael Morse, MD, Duke University Medical Center

ClinicalTrials.gov Identifier:

NCT00437502

First received: February 19, 2007

Last updated: November 15, 2012

Last verified: November 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2010
Primary Completion Date:	January 2010 (Final data collection date for primary outcome measure)

Publications: